Evidence map›Paper›PMID 35701899›Full record

ArticleNeuropathology : official journal of the Japanese Society of Neuropathology2022

Praja1 RING-finger E3 ubiquitin ligase is a common suppressor of neurodegenerative disease-associated protein aggregation.

Kazuhiko Watabe, Motoko Niida-Kawaguchi, Mari Tada, Yoichiro Kato, Makiko Murata, Kunikazu Tanji, Koichi Wakabayashi, Mitsunori Yamada, Akiyoshi Kakita, Noriyuki Shibata

Open access · hybridAbstract read
In one paragraph

Article in Neuropathology : official journal of the Japanese Society of Neuropathology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Structural and functional characterization of the brain-specific dynamin superfamily member RNF112.Proceedings of the National Academy of Sciences of the United States of America · 2025
    Article
  6. Article
  7. Functional constraints ofbioRxiv : the preprint server for biology · 2025
    Article
  8. Review
  9. Review
  10. Article
  11. Ubiquitin-modifying enzymes in Huntington's disease.Frontiers in molecular biosciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 5 institutions in 1 country.

Kazuhiko WatabeDepartment of Medical Technology (Neuropathology), Faculty of Health Sciences, Kyorin University, Tokyo, Japan.ORCID https://orcid.org/0000-0002-0245-3834
Motoko Niida-KawaguchiDivision of Pathological Neuroscience, Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.
Mari TadaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
Yoichiro KatoDivision of Pathological Neuroscience, Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0003-0777-5020
Makiko MurataDepartment of Medical Technology (Neuropathology), Faculty of Health Sciences, Kyorin University, Tokyo, Japan.
Kunikazu TanjiDepartment of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Koichi WakabayashiDepartment of Neuropathology, Institute of Brain Science, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.ORCID https://orcid.org/0000-0002-3756-7209
Mitsunori YamadaDivision of Neuropathology, Department of Brain Disease Research, Shinshu University School of Medicine, Matsumoto, Japan.
Akiyoshi KakitaDepartment of Pathology, Brain Research Institute, Niigata University, Niigata, Japan.
Noriyuki ShibataDivision of Pathological Neuroscience, Department of Pathology, Tokyo Women's Medical University, Tokyo, Japan.ORCID https://orcid.org/0000-0001-7173-5061
Kyorin University · JPHirosaki University · JPNiigata University · JPTokyo Women's Medical University · JPShinshu University · JP

Funding

Japan Society for the Promotion of Science #18K06507Niigata University 2020-2021
6 · The paper itself

Abstract

The formation of misfolded protein aggregates is one of the pathological hallmarks of neurodegenerative diseases. We have previously demonstrated the cytoplasmic aggregate formation of adenovirally expressed transactivation response DNA-binding protein of 43 kDa (TDP-43), the main constituent of neuronal cytoplasmic aggregates in cases of amyotrophic lateral sclerosis (ALS) and frontotemporal lobar degeneration (FTLD), in cultured neuronal cells under the condition of proteasome inhibition. The TDP-43 aggregate formation was markedly suppressed by co-infection of adenoviruses expressing heat shock transcription factor 1 (HSF1), a master regulator of heat shock response, and Praja1 RING-finger E3 ubiquitin ligase (PJA1) located downstream of the HSF1 pathway. In the present study, we examined other reportedly known E3 ubiquitin ligases for TDP-43, i.e. Parkin, RNF112 and RNF220, but failed to find their suppressive effects on neuronal cytoplasmic TDP-43 aggregate formation, although they all bind to TDP-43 as verified by co-immunoprecipitation. In contrast, PJA1 also binds to adenovirally expressed wild-type and mutated fused in sarcoma, superoxide dismutase 1, α-synuclein and ataxin-3, and huntingtin polyglutamine proteins in neuronal cultures and suppressed the aggregate formation of these proteins. These results suggest that PJA1 is a common sensing factor for aggregate-prone proteins to counteract their aggregation propensity, and could be a potential therapeutic target for neurodegenerative diseases that include ALS, FTLD, Parkinson's disease and polyglutamine diseases.

Indexed as

Amyotrophic Lateral SclerosisFrontotemporal Lobar DegenerationNeurodegenerative DiseasesUbiquitin-Protein LigasesAnimalsHeat Shock Transcription FactorsProtein AggregatesHeat Shock Transcription FactorsProtein AggregatesUbiquitin-Protein Ligasesfused in sarcomaPraja1superoxide dismutase 1transactivation response DNA-binding protein of 43 kDaα-synuclein

Identifiers

PMID35701899
PMCPMC10084124
OpenAlexW4282933652

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.